Who
Kleanthis Gabriel Xanthopoulos
Director
Company insider
Files Form 4 as: Director, Connect Biopharma Holdings.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Mar 2026
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | CNTB Connect Biopharma HoldingsBiotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CNTB Connect Biopharma HoldingsBiotechnology | SEC FORM 4 Code A | —3,738 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CNTB Connect Biopharma HoldingsBiotechnology | SEC FORM 4 Code A | —3,738 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CNTB Connect Biopharma HoldingsBiotechnology | SEC FORM 4 Code A | —2,816 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CNTB Connect Biopharma HoldingsBiotechnology | SEC FORM 4 Code A | —2,816 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.